Ignite Creation Date:
2024-05-06 @ 5:27 PM
Last Modification Date:
2024-10-26 @ 2:29 PM
Study NCT ID:
NCT05319587
Status:
RECRUITING
Last Update Posted:
2023-11-18
First Post:
2022-02-22
Brief Title:
Study of Liposomal Annamycin in Combination With Cytarabine for the Treatment of Subjects With Acute Myeloid Leukemia AML
Sponsor:
Moleculin Biotech Inc
Organization:
Moleculin Biotech Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-09-29
Start Date Type:
ACTUAL
Primary Completion Date:
2024-02-28
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-04-30
Completion Date Type:
ESTIMATED
First Submit Date:
2022-02-22
First Submit QC Date:
April 5 2022
Study First Post Date:
2022-04-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-14
Last Update Post Date:
2023-11-18
Last Update Post Date Type:
ACTUAL